Clinical Trial Update: Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients [NA]

View source ↗

Summary

A clinical trial evaluating prednisone priming as a treatment for chronic hepatitis B in Asian patients has been withdrawn (NCT00715715).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Chronic Hepatitis B | NA | Status: WITHDRAWN